North America Veterinary Healthcare Market Size (2024 - 2029)

The North America Veterinary Healthcare Market is projected to experience significant growth over the forecast period, driven by advancements in animal healthcare technology, increased government and animal welfare initiatives, and rising pet ownership and expenditure. The market's expansion is further supported by the growing need for medications and preventive diagnostic tools due to the increasing occurrence of diseases among companion animals. Despite these positive trends, challenges such as a shortage of veterinarians and high healthcare costs may impede the market's growth trajectory.

Market Size of North America Veterinary Healthcare Industry

North America Veterinary Healthcare Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 23.86 Billion
Market Size (2029) USD 31.48 Billion
CAGR (2024 - 2029) 5.70 %
Market Concentration Medium

Major Players

North America Veterinary Healthcare Market Major Players

*Disclaimer: Major Players sorted in no particular order

North America Veterinary Healthcare Market Analysis

The North America Veterinary Healthcare Market size is estimated at USD 23.86 billion in 2024, and is expected to reach USD 31.48 billion by 2029, growing at a CAGR of 5.70% during the forecast period (2024-2029).

The outbreak of the COVID-19 pandemic impacted the market. According to a research article published in the Canadian Veterinary Journal in April 2021, the pandemic took a toll on the veterinary healthcare industry. In 2021, there was an increase in the expenses for veterinary practices by 5%, requiring an even higher increase in professional fees. Furthermore, another article presented in the journal, Frontiers in Veterinary Science in February 2021 discussed dog owners' fears and concerns about veterinary care and obtainment of pet care products and food during the lockdown phase of the pandemic to be better prepared to address these concerns during the pandemic and in the future. The study indicated that, like many other professions, veterinarians were significantly impacted by the onset of COVID-19. Standard practices such as routine animal checkups and surgeries were disrupted, and veterinary clinics and hospitals had to quickly modify standard protocols to serve their clients and patients safely. However, with the ease of restrictions and declining cases of COVID-19, the market started to gain traction and is expected to maintain an upward trend over the forecast period.

The advanced technology leading to innovations in animal healthcare, increasing initiatives by governments and animal welfare associations, and increasing productivity at the risk of emerging zoonosis are the major drivers for the market. For instance, an article published by the Government of Canada on reportable diseases in terrestrial animals updated in February 2021 listed several diseases that affect the animals, including companion animals in the region. The large list of diseases includes equine infectious anemia, equine piroplasmosis, Newcastle disease, pullorum disease, and vesicular stomatitis among others. The increase in the occurrence of diseases among companion animals in the region and the requirement of associated medications will provide a lucrative growth of the North America veterinary healthcare market over the forecast period. In addition, the development of preventive diagnostic tools is also expected to contribute to market growth. For instance, in April 2021, AntechDiagnostics, part of Mars Veterinary Health, released new data that shows that all cats from a retrospective review of 730,000 veterinary visits received improved preventive care. The data shows that the predictive diagnostic tool increased veterinary visits by as much as 31.0%.

Increasing pet ownership and animal expenditure is also anticipated to drive market growth. For instance, according to the American Pet Products Association's 2021-2022 National Pet Owners Survey, around 69.0 million Americans owned a dog, 45.3 million owned cats, 11.8 owned freshwater fish, 9.9 million owned birds, 6.2 million owned small animals, 5.7 million owned reptiles, 3.5 million owned horses, and 2.9 million owned saltwater fish. Similarly, according to a report published by the American Pet Products Association's National Pet Owners Surveys in 2022, the United States pet industry expenditure accounted for USD 123.6 billion in 2021. Moreover, as per a report published by the North American Pet Health Insurance Association (NAPHIA) in 2021, the pet insurance sector of North America exceeded USD 2.83 billion by the end of 2021, and the industry witnessed a growth of more than double over the past four years. It also reported total premium volume for pet insurance in the United States was around USD 2.6 billion in 2021. The total number of pets insured in the United States at the end of the year 2021 was 3.9 million, which is an increase of around 28% from 2020.

While growth is expected, the lack of veterinarians and the high costs associated with animal healthcare may hinder market growth over the forecast period.

North America Veterinary Healthcare Industry Segmentation

As per the scope of the report, the veterinary healthcare market comprises therapeutic products and solutions for companion and farm animals. Veterinary healthcare can be defined as the science associated with diagnosing, treating, and preventing diseases in animals. The increasing importance of the production of livestock animals is generating growth in the veterinary healthcare market.

The North American veterinary healthcare market is segmented by Product Type (Therapeutics and Diagnostics), Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animal Types), and Geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.

By Product Type
By Therapeutics
Vaccines
Parasiticides
Anti-infectives
Medical Feed Additives
Other Therapeutics
By Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Other Animal Types
Geography
United States
Canada
Mexico
Need A Different Region Or Segment?
Customize Now

North America Veterinary Healthcare Market Size Summary

The North America Veterinary Healthcare Market is poised for significant growth over the forecast period, driven by advanced technological innovations, increased pet ownership, and heightened awareness of zoonotic diseases. The market, which experienced disruptions due to the COVID-19 pandemic, is expected to regain momentum as restrictions ease. The pandemic highlighted challenges in veterinary care, such as disrupted routine checkups and surgeries, prompting the industry to adapt quickly. The market's expansion is supported by government initiatives and animal welfare associations, which are crucial in addressing the rising incidence of diseases among companion animals. The development of preventive diagnostic tools and the increasing demand for pet insurance further contribute to the market's growth trajectory.

Key players in the industry, including Boehringer Ingelheim, Ceva Holdings, Eli Lilly (Elanco Animal Health), Idexx Laboratories, and Merck & Co., are actively enhancing their product offerings and expanding their presence in the region. The acquisition of Canadian firm Artemis Technologies by Ceva Santé Animale is a notable example of strategic expansion. Additionally, the introduction of new diagnostic and treatment solutions, such as those by Idexx Laboratories, underscores the industry's commitment to improving animal health outcomes. Despite challenges like a shortage of veterinarians and high healthcare costs, the market is expected to thrive, supported by a well-structured healthcare system and favorable policies in the U.S. and Canada that encourage research and development.

Explore More

North America Veterinary Healthcare Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Advanced Technology Leading to Innovations in Animal Healthcare

      2. 1.2.2 Increasing Initiatives by Governments and Animal Welfare Associations

      3. 1.2.3 Increasing Productivity at the Risk of Emerging Zoonosis

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Veterinarians

      2. 1.3.2 High Costs Associated With Animal Healthcare

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Buyers/Consumers

      2. 1.4.2 Bargaining Power of Suppliers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product Type

      1. 2.1.1 By Therapeutics

        1. 2.1.1.1 Vaccines

        2. 2.1.1.2 Parasiticides

        3. 2.1.1.3 Anti-infectives

        4. 2.1.1.4 Medical Feed Additives

        5. 2.1.1.5 Other Therapeutics

      2. 2.1.2 By Diagnostics

        1. 2.1.2.1 Immunodiagnostic Tests

        2. 2.1.2.2 Molecular Diagnostics

        3. 2.1.2.3 Diagnostic Imaging

        4. 2.1.2.4 Clinical Chemistry

        5. 2.1.2.5 Other Diagnostics

      3. 2.1.3 By Animal Type

        1. 2.1.3.1 Dogs and Cats

        2. 2.1.3.2 Horses

        3. 2.1.3.3 Ruminants

        4. 2.1.3.4 Swine

        5. 2.1.3.5 Poultry

        6. 2.1.3.6 Other Animal Types

    2. 2.2 Geography

      1. 2.2.1 United States

      2. 2.2.2 Canada

      3. 2.2.3 Mexico

North America Veterinary Healthcare Market Size FAQs

The North America Veterinary Healthcare Market size is expected to reach USD 23.86 billion in 2024 and grow at a CAGR of 5.70% to reach USD 31.48 billion by 2029.

In 2024, the North America Veterinary Healthcare Market size is expected to reach USD 23.86 billion.

North America Veterinary Healthcare Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)